An introduction to Talisman Therapeutics by Dr. Martin Crossley, alongside some context on why this work is so important – the current and projected trends in global dementia research and care:


Dr. Tom Campbell introduces Talisman’s proprietary neuron-microglia co-cultures, and presents recent data characterising the network dynamics and neuroinflammatory phenotypes of these complex, fully human systems: